Direct current cardioversion for symptomatic atrial fibrillation or flutter is feasible and safe in patients implanted with the Watchman left atrial appendage (LAA) occlusion device, even in the ...

A Food and Drug Administration (FDA) advisory committee has voted 11 to 2 against a recommendation that the agency approve a long-studied antiarrhythmic agent for cardioversion of recent-onset atrial ...

Patients with recent-onset atrial fibrillation commonly undergo immediate restoration of sinus rhythm by pharmacologic or electrical cardioversion. However, whether immediate restoration of sinus ...

Cardioversion is a procedure used to restore a normal heart rhythm. It’s most often used to treat AFib, the most common type of heart arrhythmia. While some people have success with medications, most ...

Cardiologists at University of Utah Health use this therapy for people with heart rhythm disorders (arrhythmias), including atrial flutter and atrial fibrillation (AFib). Your heart’s electrical ...

ATRIAL fibrillation is one of the most prevalent of the chronic rhythm disorders of the heart. It is a derangement with serious implications. Even when the patient is asymptomatic the arrhythmia is by ...

VANCOUVER, June 12, 2015 /CNW/ - Cardiome Pharma Corp. (NASDAQ: CRME /TSX: COM) today announced that an independent study conducted by investigators at the University of Leipzig Heart Center, Germany, ...

Atrial fibrillation (AFib) is a kind of irregular heartbeat, or arrhythmia. A problem with the electrical signals that control your heart’s pumping action causes it to beat too fast in a pattern that ...

In the TEE (+) group, LAAT was observed in 26 patients (7.18%). None of the patients had a thromboembolic event within the first month of follow-up. In this observational study, we investigated ...